Capital expenditure decreased 77.8%
Capital expenditure changed -77.8% from the comparable as-filed period.
$294,550→$65,4793 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →OSS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed across a sign change
Operating income changed -246.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$570,102→-$834,7103 prior comparisons
Receivables / revenue moved 3716 bp higher
Receivables / revenue changed +3716 basis points from the comparable as-filed period.
64.11%→101.27%3 prior comparisons
Cash & equivalents decreased 13.4%
Cash & equivalents changed -13.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$6.5M→$5.6M4 prior comparisons
Research & development decreased 23.4%
Research & development changed -23.4% from the comparable as-filed period.
$1.4M→$1.1M3 prior comparisons
Gross profit decreased 19.9%
Gross profit changed -19.9% from the comparable as-filed period.
$6.7M→$5.4M3 prior comparisons
Capex / revenue moved 105 bp lower
Capex / revenue changed -105 basis points from the comparable as-filed period.
1.57%→0.52%3 prior comparisons
Inventory decreased 10.5%
Inventory changed -10.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$15.3M→$13.7M4 prior comparisons
Total assets increased 10.1%
Total assets changed +10.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$43.1M→$47.4M4 prior comparisons
Trade receivables increased 6.0%
Trade receivables changed +6.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$12.0M→$12.7M4 prior comparisons
Shares outstanding increased 2.1%
Shares outstanding changed +2.1% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes.
24,515,491→25,037,4458 prior comparisons
R&D / revenue moved 110 bp higher
R&D / revenue changed +110 basis points from the comparable as-filed period.
7.72%→8.82%3 prior comparisons
Receivables / revenue moved 3883 bp higher
Receivables / revenue changed +3883 basis points from the comparable as-filed period.
50.41%→89.24%3 prior comparisons
Working capital / assets moved 935 bp higher
Working capital / assets changed +935 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
58.85%→68.20%4 prior comparisons
Shares outstanding increased 13.8%
Shares outstanding changed +13.8% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
21,924,818→24,940,1308 prior comparisons
Capital expenditure decreased 31.2%
Capital expenditure changed -31.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$160,536→$110,3924 prior comparisons
R&D / revenue moved 168 bp lower
R&D / revenue changed -168 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
10.81%→9.13%3 prior comparisons
Trade receivables increased 17.3%
Trade receivables changed +17.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$7.1M→$8.3M4 prior comparisons
Gross profit decreased 17.3%
Gross profit changed -17.3% from the comparable as-filed period.
$4.4M→$3.7M3 prior comparisons
Capex / revenue moved 4 bp higher
Capex / revenue changed +4 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
1.14%→1.18%3 prior comparisons
Inventory decreased 5.0%
Inventory changed -5.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$14.6M→$13.9M4 prior comparisons
Selling, general & administrative increased 2.8%
Selling, general & administrative changed +2.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$2.4M→$2.5M3 prior comparisons
Current ratio decreased 4.0%
Current ratio changed -4.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
3.51→3.374 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.